1. Home
  2. SRRK vs APPF Comparison

SRRK vs APPF Comparison

Compare SRRK & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$47.49

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo AppFolio Inc.

APPF

AppFolio Inc.

HOLD

Current Price

$180.69

Market Cap

6.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
APPF
Founded
2012
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.6B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
SRRK
APPF
Price
$47.49
$180.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
9
Target Price
$56.17
$286.78
AVG Volume (30 Days)
1.0M
367.7K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.36
Revenue
N/A
$950,822,000.00
Revenue This Year
N/A
$19.69
Revenue Next Year
$534.24
$16.70
P/E Ratio
N/A
$76.35
Revenue Growth
N/A
19.72
52 Week Low
$27.07
$142.56
52 Week High
$58.49
$323.34

Technical Indicators

Market Signals
Indicator
SRRK
APPF
Relative Strength Index (RSI) 39.11 55.37
Support Level $45.83 $157.79
Resistance Level $48.23 $187.38
Average True Range (ATR) 2.20 8.39
MACD -0.65 0.27
Stochastic Oscillator 5.15 64.28

Price Performance

Historical Comparison
SRRK
APPF

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About APPF AppFolio Inc.

AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.

Share on Social Networks: